Pyxis Oncology (PYXS) Competitors $1.21 -0.02 (-1.63%) As of 05/20/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PYXS vs. ACB, AQST, CMPX, DBVT, CRVS, IMMP, RNAC, AURA, CGC, and TSVTShould you be buying Pyxis Oncology stock or one of its competitors? The main competitors of Pyxis Oncology include Aurora Cannabis (ACB), Aquestive Therapeutics (AQST), Compass Therapeutics (CMPX), DBV Technologies (DBVT), Corvus Pharmaceuticals (CRVS), Immutep (IMMP), Cartesian Therapeutics (RNAC), Aura Biosciences (AURA), Canopy Growth (CGC), and 2seventy bio (TSVT). These companies are all part of the "pharmaceutical products" industry. Pyxis Oncology vs. Aurora Cannabis Aquestive Therapeutics Compass Therapeutics DBV Technologies Corvus Pharmaceuticals Immutep Cartesian Therapeutics Aura Biosciences Canopy Growth 2seventy bio Pyxis Oncology (NASDAQ:PYXS) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, earnings, dividends, profitability, risk, valuation, analyst recommendations and community ranking. Do analysts recommend PYXS or ACB? Pyxis Oncology presently has a consensus price target of $9.00, suggesting a potential upside of 643.80%. Given Pyxis Oncology's higher possible upside, analysts clearly believe Pyxis Oncology is more favorable than Aurora Cannabis.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pyxis Oncology 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80Aurora Cannabis 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.67 Which has higher valuation and earnings, PYXS or ACB? Aurora Cannabis has higher revenue and earnings than Pyxis Oncology. Pyxis Oncology is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPyxis Oncology$16.15M4.64-$73.79M-$1.30-0.93Aurora Cannabis$320.81M0.94-$48.62M$0.05106.80 Is PYXS or ACB more profitable? Aurora Cannabis has a net margin of 0.42% compared to Pyxis Oncology's net margin of 0.00%. Aurora Cannabis' return on equity of 0.59% beat Pyxis Oncology's return on equity.Company Net Margins Return on Equity Return on Assets Pyxis OncologyN/A -36.22% -28.76% Aurora Cannabis 0.42%0.59%0.42% Which has more risk & volatility, PYXS or ACB? Pyxis Oncology has a beta of 1.15, indicating that its stock price is 15% more volatile than the S&P 500. Comparatively, Aurora Cannabis has a beta of 1.94, indicating that its stock price is 94% more volatile than the S&P 500. Does the media favor PYXS or ACB? In the previous week, Pyxis Oncology had 9 more articles in the media than Aurora Cannabis. MarketBeat recorded 10 mentions for Pyxis Oncology and 1 mentions for Aurora Cannabis. Pyxis Oncology's average media sentiment score of 0.60 beat Aurora Cannabis' score of 0.38 indicating that Pyxis Oncology is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pyxis Oncology 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Aurora Cannabis 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders and institutionals believe in PYXS or ACB? 39.1% of Pyxis Oncology shares are held by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are held by institutional investors. 10.6% of Pyxis Oncology shares are held by insiders. Comparatively, 0.0% of Aurora Cannabis shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the MarketBeat Community believe in PYXS or ACB? Aurora Cannabis received 353 more outperform votes than Pyxis Oncology when rated by MarketBeat users. However, 83.78% of users gave Pyxis Oncology an outperform vote while only 59.63% of users gave Aurora Cannabis an outperform vote. CompanyUnderperformOutperformPyxis OncologyOutperform Votes3183.78% Underperform Votes616.22%Aurora CannabisOutperform Votes38459.63% Underperform Votes26040.37% SummaryAurora Cannabis beats Pyxis Oncology on 12 of the 19 factors compared between the two stocks. Get Pyxis Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for PYXS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PYXS vs. The Competition Export to ExcelMetricPyxis OncologyPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$74.96M$6.55B$5.43B$8.48BDividend YieldN/A2.66%5.22%4.11%P/E Ratio-1.179.1426.8320.05Price / Sales4.64255.59393.86119.28Price / CashN/A65.8538.2534.62Price / Book0.436.546.874.61Net Income-$73.79M$143.51M$3.22B$248.19M7 Day Performance1.68%4.66%5.65%2.88%1 Month Performance25.61%10.63%13.54%15.40%1 Year Performance-71.12%-1.05%18.16%7.68% Pyxis Oncology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PYXSPyxis Oncology1.4469 of 5 stars$1.21-1.6%$9.00+643.8%-71.1%$76.20M$16.15M-1.1760News CoverageEarnings ReportAnalyst ForecastAnalyst RevisionGap UpACBAurora Cannabis0.4589 of 5 stars$5.06+4.3%N/A-27.8%$284.44M$320.81M101.221,340Gap UpAQSTAquestive Therapeutics1.3276 of 5 stars$2.85+2.2%$10.67+274.3%-25.1%$283.07M$57.56M-6.33160News CoveragePositive NewsAnalyst RevisionGap UpCMPXCompass Therapeutics3.7948 of 5 stars$2.01+10.4%$13.13+553.0%+31.3%$277.95M$850,000.00-5.4320DBVTDBV Technologies3.0275 of 5 stars$10.13+3.1%$15.50+53.0%+52.4%$277.46M$15.73M-2.2580CRVSCorvus Pharmaceuticals2.4369 of 5 stars$4.05-8.6%$16.33+303.3%+61.4%$276.08MN/A-4.3530Analyst ForecastHigh Trading VolumeIMMPImmutep1.5725 of 5 stars$1.87+1.1%$8.50+354.5%-35.2%$273.09M$5.14M0.002,021RNACCartesian Therapeutics1.5659 of 5 stars$10.44+5.5%$42.50+307.1%-60.4%$270.78M$38.91M-0.2064News CoverageAnalyst RevisionAURAAura Biosciences2.4335 of 5 stars$5.35+2.3%$22.75+325.2%-16.5%$268.70MN/A-3.0950Earnings ReportInsider TradeCGCCanopy Growth1.428 of 5 stars$1.46+11.5%$2.00+37.0%-82.5%$268.44M$276.75M-0.383,150Trending NewsGap UpTSVT2seventy bio1.54 of 5 stars$5.00+0.2%$4.25-15.0%N/A$266.15M$37.86M-2.69440News CoveragePositive News Related Companies and Tools Related Companies ACB Alternatives AQST Alternatives CMPX Alternatives DBVT Alternatives CRVS Alternatives IMMP Alternatives RNAC Alternatives AURA Alternatives CGC Alternatives TSVT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PYXS) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pyxis Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pyxis Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PYXS Stock Free PYXS Stock Alerts